SCHEMBL30393198

SCHEMBL30393198

CCN1CCC(Oc2cc3c(-c4ccc(C(C(N)=O)c5ccc(C(F)(F)F)cc5)cc4)ncnc3cc2OC)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 8/20 0.50
▸ ERBB2 P04626 11/20 0.46
▸ MAPK7 Q13164 1/20 0.45
▸ GAK O14976 1/20 0.41
▸ RIPK2 O43353 1/20 0.41
▸ LYN P07948 1/20 0.41
▸ RET P07949 1/20 0.41
▸ EPHA1 P21709 1/20 0.41
▸ ERBB3 P21860 1/20 0.41
▸ EPHA2 P29317 1/20 0.41
▸ EPHB2 P29323 1/20 0.41
▸ EPHA5 P54756 1/20 0.41
▸ EPHB4 P54760 1/20 0.41
▸ EPHA4 P54764 1/20 0.41
▸ ADK P55263 1/20 0.41
▸ PTK6 Q13882 1/20 0.41
▸ RIPK3 Q9Y572 1/20 0.41
▸ KIT P10721 2/20 0.41
▸ PDE10A Q9Y233 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26099028 1.00 EGFR (0.50) EGFRERBB2MAPK7GAKRIPK2
SCHEMBL26103141 0.96 EGFR (0.49) EGFRERBB2MAPK7KITPDE10A
SCHEMBL26103317 0.92 EGFR (0.48) EGFRERBB2MAPK7KITPDE10A
SCHEMBL30891778 0.90 MAPK7 (0.45) EGFRERBB2MAPK7GAKRIPK2
SCHEMBL26099862 0.90 MAPK7 (0.45) EGFRERBB2MAPK7GAKRIPK2
SCHEMBL26103463 0.88 MAPK7 (0.44) EGFRERBB2MAPK7EPHA2EPHB4
SCHEMBL26100926 0.88 EGFR (0.47) EGFRERBB2MAPK7KIT
SCHEMBL26102740 0.86 EGFR (0.45) EGFRERBB2MAPK7EPHA2EPHB4
SCHEMBL26101576 0.86 EGFR (0.45) EGFRERBB2MAPK7KITPDE10A
SCHEMBL26135306 0.86 EGFR (0.45) EGFRERBB2MAPK7KITPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201909-A Quinazoline derivative compound and use thereof 株式会社沃若诺伊 2024-06-14 — — CN disclosed
WO-2023075529-A1 QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF 보로노이바이오 주식회사 2023-05-04 — — WO disclosed
Send feedback